This analysis examined the effects of behavioral programs on the health outcomes of patients with type 1 diabetes (T1D).  The authors concluded that behavioral programs for T1D offer some benefit for glycemic (blood sugar level) control. 

This study examined whether urinary adiponectin can predict the progression of diabetic kidney disease.

This article summarizes a presentation on the treatment of autonomic diabetic neuropathy in the gut (gastroparesis). The presentation was given at the 2015 annual meeting of the European Association for the Study of Diabetes (EASD). The article concluded that the first goal of treatment is to tightly control blood sugar to prevent autonomic neuropathy from progressing.

This study examined the effect of lifetime depression and anxiety on current psychological symptoms and diabetes behavior and control in patients with type 2 diabetes (T2D).

This study compared the effects of Lusefi (luseogliflozin) in people with type 2 diabetes (T2D) who had different carbohydrate intakes. It determined that luseogliflozin reduced glucose levels, regardless of carbohydrate intake.

This review examined the factors which make a behavioral program for type 2 diabetes management effective. The authors concluded that patients who have poorly controlled diabetes are likely to gain the greatest benefit.

This study examined whether meal sequence affects blood glucose levels in individuals with type 2 diabetes. The authors concluded that meal sequence affects blood glucose levels after a meal and nutritional therapy may be important in managing type 2 diabetes.

This study examined bone density, structure and fractures in patients with diabetes.  The study concluded that type 1 diabetes patients had a lower bone mineral density (BMD, the amount of calcium in your bones) at the hipbone and lower bone stiffness at the shinbone than type 2 diabetes patients. Sclerostin, a protein, was associated with the risk of fracture. 

This study examined whether Ly 2963016 insulin glargine is safe and effective in type 1 diabetics.

This study examined whether there is a link between type 2 diabetes (T2D) and osteoarthritis. They found that patients with T2D were more likely to develop osteoarthritis.